Real-world Use of Prophylaxis in People with Non-Severe Hemophilia in the United States: Insights from the ATHN Transcends Study – Hemophilia Natural History Arm – Winner of ASH Abstract Achievement Award!
Author(s):
Fernando F. Corrales-Medina, Nana Ama Afari-Dwamena, Amanda Blair, Shannon L. Carpenter, Clay T. Cohen, Maissaa Janbain, Janice M. Staber, Jonathan Schwartz, Michael Recht, Tammuella Chrisentery-Singleton
Safety and Effectiveness of Emicizumab in People With Haemophilia A Enrolled in the ATHN 7 Haemophilia Natural History Study
Author(s):
Tyler W. Buckner, Shannon L. Carpenter, Nabil Daoud, Christine L. Kempton, Lucy Lee, Lynn Malec, Thomas W. McLean, Paul Morton, Carrie O’Neill, Janice M. Staber, Michael Wang, Stacy E. Croteau, Michael Recht
Bleed treatment with eptacog beta (rFVIIa) results in a low incidence of rebleeding in adult and adolescent patients with hemophilia A or B with inhibitors
Author(s):
Amy Dunn, Yesim Dargaud, Yasmina Abajas, Manuel Carcao, Giancarlo Castaman, Adam Giermasz, Cédric Hermans, Victor Jimenez-Yuste, Magdalena Lewandowska, Johnny Mahlangu, Shannon Meeks, Wolfgang Miesbach, Michael Recht, Vanessa Salinas-Luna, Tammuella Chrisentery-Singleton, Daniel Bonzo, Ian Mitchell, Thomas A. Wilkinson, Guy Young